Cordyceps sinensis shows promise in treating sepsis-associated acute kidney injury

FHS
August 7, 2024
11:54 pm

Announcing a new publication for Acta Materia Medica journal. Cordyceps sinensis (CS) has been widely used as a dietary supplement or traditional medicine for the prevention, treatment, and prognostication of various diseases, because of its pleiotropic pharmacological properties.

4 Tech Strategies to Improve Patient Medication Adherence in 2025

Clifford Jones, Founder and CTO, AllazoHealth Patient adherence has been a top priority in healthcare for quite some time. One in five new prescriptions are

January 2, 2025

Azurity’s Nymalize solution in prefilled syringe gains FDA approval

Nymalize is indicated for use in adult patients with subarachnoid haemorrhage from ruptured intracranial berry aneurysms. Credit: Radiological imaging/Shutterstock. Azurity Pharmaceuticals’ Nymalize (nimodipine) oral solution

September 4, 2024

Vance on ACA, diagnosing myopia, and fallout from a retracted study

In a story today from STAT’s Anil Oza, I learned that researcher and physician Alex Keuroghlian recently wrote the first editorial on transgender health research

September 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.